Clinical trial Recruiting at 5 sites Observational Ages Any age to 50

Prenatal maternal mental health and infant brain development in congenital heart defects

Official title: Prenatal Maternal Mental Health and Neurodevelopment in Children With an Antenatal Diagnosis of Congenital Heart Disease: The Neuro-Moms CHD Study

Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT06711666 · Data updated 2026-11-12

See if prenatal maternal psychological distress is linked to neurodevelopment at age one in babies with prenatally diagnosed critical cyanotic congenital heart defects who need neonatal open-heart surgery.

More Congenital Heart Disease trials

Quick facts

Study typeObservational
AgesAny age to 50 Years
SexAll
Enrollment174 (estimated)
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
Government
Locations5 sites (Marseille and 4 other locations)
StatusRecruiting
StartedJune 27, 2025
Main results expectedOctober 2028
Study endsFebruary 2029
Registry record updatedJuly 30, 2026
Trial IDNCT06711666 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Expecting women aged 18+ between 28 and 38 weeks gestation with a prenatal diagnosis of a critical cyanotic CHD requiring neonatal open-heart surgery, receiving follow-up at one of the participating French hospitals and covered by French social security (co-parents aged 18+ may also participate).

Probably not a fit

Pregnant people whose fetus does not have a prenatal diagnosis of critical cyanotic CHD, whose infants will not require neonatal open-heart surgery, or who cannot attend participating hospitals in France are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, longitudinal observational study enrolling expecting mothers after 28 weeks gestation who have received a prenatal diagnosis of a critical cyanotic congenital heart defect requiring neonatal open-heart surgery. Participants undergo comprehensive maternal psychological evaluations by perinatal mental health professionals and standardized self-report measures, with co-parents completing questionnaires at baseline. Assessments occur at three time points: late pregnancy, before neonatal hospital discharge after surgery, and at the child's first birthday (12–18 months). The study follows children from the third trimester through their first year to relate prenatal parental mental health to early neurodevelopmental and behavioral outcomes.

Why it matters

Potential benefit: If successful, the findings could identify parental mental health factors that, when addressed, may improve early neurodevelopmental outcomes for infants with critical CHD.

How similar studies have gone: Prior research in the general population links prenatal maternal distress to adverse child neurodevelopment, but effects specifically in infants with critical CHD are largely untested, making this approach relatively novel for this group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for the mother of a child diagnosed with CHD:

1. Age at least 18 years old
2. Expecting women
3. Having received a diagnosis of foetal critical cyanotic CHD (i.e., CHD physiology that can compromise blood oxygenation after birth). This type of CHDs corresponds to the highest level of neurological risk as reported by the American Heart Association guidelines(1).
4. Pregnancy of at least 28 weeks of gestation (third trimester) and up to the 38 weeks of gestation at the time of enrolment and prenatal visit for the study.
5. Medical maternal and paediatric cardiology follow-up in one of the investigating hospitals (Montpellier, Necker Children's Hospital in Paris and Bordeaux).
6. A delay of a minimum of 4 weeks between the initial diagnosis of foetal congenital heart disease.
7. Social security affiliation in France.

Inclusion criteria for the father or co-parent:

1. Co-parent of an expecting woman participating in the study
2. Age at least 18 years old
3. Social security affiliation in France.

Inclusion criteria for the child diagnosed with congenital heart disease:

1. Child with a prenatal diagnosis of isolated complex congenital heart disease, born to a mother already participating in the study
2. Written consent from both parents
3. Social security affiliation in France.

Non-inclusion Criteria for mothers:

1. Patient refusal to participate
2. Participants (i.e., expecting women) who express a wish for medical termination of pregnancy
3. Diagnosis of a complex CHD associated with another foetal comorbidity with a clinically recognized impact on neurodevelopment (e.g., genetic syndromes such as trisomies, poly-malformation syndromes).
4. Participants who are not able to understand the instructions and/or complete the self-reports
5. Expecting women who currently have a major psychiatric condition (e.g., untreated major depression, severe anxiety disorders, psychotic disorders) with or without treatment, at the time of the cardiology consultation or at the time of the first psychological evaluation. Patients who will be excluded due to these conditions will be referred for perinatal psychiatric consultation.
6. Persons under legal or judicial guardianship.

Non-inclusion Criteria for fathers or co-parents:

1. Patient refusal to participate
2. Participants with a severe psychiatric disorder (severe depression, psychotic disorders) with or without treatment
3. Persons under legal or judicial guardianship.

Exclusion Criteria for the mother of a child diagnosed with CHD:

1\. The child has not undergone surgery within 60 days of birth.

Exclusion Criteria for children with CHD:

1\. Genetic anomalies, brain malformations that may render difficult the neurodevelopmental assessment.

Where it's running

  • Hopital de Marseille la Timone
    Marseille, France
    Recruiting
  • CHU de Montpellier
    Montpellier, France
    Recruiting
  • Institut Saint Pierre
    Palavas-les-Flots, France
    Recruiting
  • Hopital Necker Enfants Malades
    Paris, France
    Recruiting
  • Hopital Haut Leveque
    Pessac, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.